ストックスクリーナーアプリを入手
11.82
3.32%
0.38
アフターアワーズ：
11.80
-0.02
-0.17%
前日終値:
$11.44
開ける：
$11.68
24時間の取引高:
506.43K
Relative Volume:
0.69
時価総額：
$354.48M
収益：
$40.61M
当期純損益:
$-29.07M
株価収益率:
-11.73
EPS:
-1.0081
ネットキャッシュフロー:
$-26.70M
1週間 パフォーマンス:
+5.82%
1か月 パフォーマンス:
+0.34%
6か月 パフォーマンス:
-18.14%
1年 パフォーマンス:
-0.59%
1日の値動き範囲:
$11.42
$12.33
1週間の範囲:
$10.94
$12.33
52週間の値動き範囲:
$8.27
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
名前
Clearpoint Neuro Inc
セクター
電話
(949) 900-6833
住所
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
11.82 | 343.08M | 40.61M | -29.07M | -26.70M | -1.0081 |
ABT
Abbott Laboratories
|
86.67 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
313.00 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.60 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.64 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.54 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-25 | 再開されました | B. Riley Securities | Buy |
| 2023-10-24 | 開始されました | Stifel | Buy |
| 2023-02-16 | 再開されました | B. Riley Securities | Buy |
| 2022-04-05 | 再開されました | B. Riley Securities | Buy |
| 2021-03-18 | 開始されました | Lake Street | Buy |
| 2020-07-17 | 開始されました | B. Riley FBR | Buy |
すべてを表示
Clearpoint Neuro Inc (CLPT) 最新ニュース
ClearPoint Neuro (CLPT) director receives grant of 12,820 RSUs - Stock Titan
ClearPoint Neuro (CLPT) director receives 12,820 restricted stock units in equity grant - Stock Titan
[Form 4] ClearPoint Neuro, Inc. Insider Trading Activity - Stock Titan
Director at ClearPoint Neuro (CLPT) receives 12,820 restricted stock units - Stock Titan
Director at ClearPoint Neuro (NASDAQ: CLPT) awarded 12,820 RSUs - Stock Titan
Director Matthew Klein of ClearPoint Neuro (CLPT) receives 12,417 shares from RSU vesting - Stock Titan
Tax sale by ClearPoint (CLPT) director after RSU vesting - Stock Titan
Director at ClearPoint Neuro (NASDAQ: CLPT) gains 12,417 shares via RSU vesting - Stock Titan
ClearPoint Neuro (CLPT) investors approve directors, pay and updated incentive plan - Stock Titan
ClearPoint Neuro (CLPT) director converts 12,417 RSUs into common shares - Stock Titan
ClearPoint Neuro (CLPT) director settles 12,417 RSUs into common stock - Stock Titan
Director Pascal Girin converts 12,417 RSUs into ClearPoint Neuro (CLPT) common shares - Stock Titan
ClearPoint Neuro (CLPT) director converts 12,417 RSUs into common stock holdings - Stock Titan
16,000-share sale by CLPT (NASDAQ: CLPT) from vested restricted plan - Stock Titan
ClearPoint Neuro Earnings Call Signals Growth With Strain - TipRanks
Compared to estimates, ClearPoint Neuro (CLPT) Q1 earnings: A look at key metrics - MSN
[144] ClearPoint Neuro, Inc. SEC Filing - Stock Titan
ClearPoint Neuro Inc (CLPT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth By GuruFocus - Investing.com Canada
Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - MSN
Avoiding Lag: Real-Time Signals in (CLPT) Movement - Stock Traders Daily
ClearPoint Neuro stock (US18507C1099): MAK Capital discloses 6.3% passive stake in CLPT - AD HOC NEWS
MAK Capital reports 6.3% stake in ClearPoint Neuro (CLPT) via Schedule 13G/A - Stock Titan
ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint - ACCESS Newswire
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q1 2026 Earnings Call Transcript - Insider Monkey
Stifel reiterates Clearpoint Neuro stock Buy rating after Q1 beat - Investing.com UK
Stifel Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $16 - Moomoo
Stifel reiterates Clearpoint Neuro stock Buy rating after Q1 beat By Investing.com - Investing.com Nigeria
ClearPoint Neuro stock (US18507C1099): Q1 revenue surges 43% to $12.1M - AD HOC NEWS
ClearPoint Neuro Inc.Common Stock (NQ: CLPT - FinancialContent
ClearPoint Neuro, Inc. Q1 2026 earnings preview - MSN
ClearPoint Neuro (CLPT) Reports Record Q1 Revenue of $12.1 Milli - GuruFocus
ClearPoint Neuro Secures CE Marking for Surgical Drill System - Moomoo
ClearPoint forecasts $52m-$56m 2026 revenue range as IRRAflow could be cash neutral as early as 2027 - MSN
ClearPoint Neuro surgical drill receives CE Mark approval - Investing.com UK
Is ClearPoint Neuro (CLPT) 14.8% Undervalued After Q1 2026? EPS - GuruFocus
CLPT Targets Reduced Cash Burn Post-IRRAS Acquisition - GuruFocus
ClearPoint Neuro Q1 Earnings Call Highlights - sharewise.com
ClearPoint Neuro, Inc. (CLPT) reports Q1 loss, lags revenue estimates - MSN
ClearPoint Neuro (CLPT) Gains CE Mark for New Surgical Drill Sys - GuruFocus
CLPT Reports Strong Q1 Revenue Growth in Neurosurgery Sector - GuruFocus
ClearPoint Neuro secures CE mark for Velocity Alpha MR surgical drill system to expand global reach - Traders Union
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates - sharewise.com
Compared to Estimates, ClearPoint Neuro (CLPT) Q1 Earnings: A Look at Key Metrics - sharewise.com
Earnings call transcript: ClearPoint Neuro Q1 2026 results miss forecasts By Investing.com - Investing.com India
Clearpoint Neuro earnings missed by $0.09, revenue fell short of estimates - Investing.com Canada
ClearPoint (CLPT) Q1 2026 Earnings Transcript - The Globe and Mail
Earnings call transcript: ClearPoint Neuro Q1 2026 results miss forecasts - Investing.com
CLPT: Q1 revenue up 43% to $12.1M; 2026 guidance $52–$56M with strong IRRAflow contribution - TradingView
ClearPoint Neuro Q1 2026 Earnings Call Transcript - Yahoo Finance
Clearpoint Neuro Inc (CLPT) 財務データ
収益
当期純利益
現金流量
EPS
1.27%
2.05%
大文字化:
|
ボリューム (24 時間):